生体機能性ペプチドの世界市場見通し2023年-2029年

◆英語タイトル：Biofunctional Peptide Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB0185）

◆商品コード：MMG23FB0185
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の生体機能性ペプチド市場規模と予測を収録しています。・世界の生体機能性ペプチド市場：売上、2018年-2023年、2024年-2029年
・世界の生体機能性ペプチド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生体機能性ペプチド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物性」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

生体機能性ペプチドのグローバル主要企業は、American Peptide Company Inc.、Phermpep Co. Ltd.、ALEXIS Corporation、Ashland Inc.、Promega Corporation、Advanced Bioconcept Company、Arlak Biotech、WN Pharmaceuticals Ltd.、Anaspec Inc.、Thermo Fisher Scientific、Seagarden AS、Novo Nordisk A/S、Merck KGaAなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、生体機能性ペプチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の生体機能性ペプチド市場：タイプ別、2018年-2023年、2024年-2029年
世界の生体機能性ペプチド市場：タイプ別市場シェア、2022年
・動物性、植物性

世界の生体機能性ペプチド市場：用途別、2018年-2023年、2024年-2029年
世界の生体機能性ペプチド市場：用途別市場シェア、2022年
・食品・飲料、化粧品、その他

世界の生体機能性ペプチド市場：地域・国別、2018年-2023年、2024年-2029年
世界の生体機能性ペプチド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における生体機能性ペプチドのグローバル売上、2018年-2023年
・主要企業における生体機能性ペプチドのグローバル売上シェア、2022年
・主要企業における生体機能性ペプチドのグローバル販売量、2018年-2023年
・主要企業における生体機能性ペプチドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
American Peptide Company Inc.、Phermpep Co. Ltd.、ALEXIS Corporation、Ashland Inc.、Promega Corporation、Advanced Bioconcept Company、Arlak Biotech、WN Pharmaceuticals Ltd.、Anaspec Inc.、Thermo Fisher Scientific、Seagarden AS、Novo Nordisk A/S、Merck KGaA

*************************************************************

・調査・分析レポートの概要
生体機能性ペプチド市場の定義
市場セグメント
世界の生体機能性ペプチド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生体機能性ペプチド市場規模
世界の生体機能性ペプチド市場規模：2022年 VS 2029年
世界の生体機能性ペプチド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生体機能性ペプチドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生体機能性ペプチド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：動物性、植物性
生体機能性ペプチドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：食品・飲料、化粧品、その他
生体機能性ペプチドの用途別グローバル売上・予測

・地域別市場分析
地域別生体機能性ペプチド市場規模 2022年と2029年
地域別生体機能性ペプチド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
American Peptide Company Inc.、Phermpep Co. Ltd.、ALEXIS Corporation、Ashland Inc.、Promega Corporation、Advanced Bioconcept Company、Arlak Biotech、WN Pharmaceuticals Ltd.、Anaspec Inc.、Thermo Fisher Scientific、Seagarden AS、Novo Nordisk A/S、Merck KGaA
...

This report aims to provide a comprehensive presentation of the global market for Biofunctional Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biofunctional Peptide. This report contains market size and forecasts of Biofunctional Peptide in global, including the following market information:
Global Biofunctional Peptide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biofunctional Peptide Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Biofunctional Peptide companies in 2022 (%)
The global Biofunctional Peptide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Animal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biofunctional Peptide include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Ashland Inc., Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd. and Anaspec Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biofunctional Peptide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Biofunctional Peptide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Biofunctional Peptide Market Segment Percentages, by Type, 2022 (%)
Animal
Vegetal
Global Biofunctional Peptide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Biofunctional Peptide Market Segment Percentages, by Application, 2022 (%)
Food and Beverages
Cosmetics
Others
Global Biofunctional Peptide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Biofunctional Peptide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biofunctional Peptide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biofunctional Peptide revenues share in global market, 2022 (%)
Key companies Biofunctional Peptide sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Biofunctional Peptide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Ashland Inc.
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
Merck KGaA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biofunctional Peptide, market overview.
Chapter 2: Global Biofunctional Peptide market size in revenue and volume.
Chapter 3: Detailed analysis of Biofunctional Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biofunctional Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biofunctional Peptide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biofunctional Peptide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biofunctional Peptide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biofunctional Peptide Overall Market Size
2.1 Global Biofunctional Peptide Market Size: 2022 VS 2029
2.2 Global Biofunctional Peptide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biofunctional Peptide Sales: 2018-2029
3 Company Landscape
3.1 Top Biofunctional Peptide Players in Global Market
3.2 Top Global Biofunctional Peptide Companies Ranked by Revenue
3.3 Global Biofunctional Peptide Revenue by Companies
3.4 Global Biofunctional Peptide Sales by Companies
3.5 Global Biofunctional Peptide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biofunctional Peptide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biofunctional Peptide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biofunctional Peptide Players in Global Market
3.8.1 List of Global Tier 1 Biofunctional Peptide Companies
3.8.2 List of Global Tier 2 and Tier 3 Biofunctional Peptide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biofunctional Peptide Market Size Markets, 2022 & 2029
4.1.2 Animal
4.1.3 Vegetal
4.2 By Type – Global Biofunctional Peptide Revenue & Forecasts
4.2.1 By Type – Global Biofunctional Peptide Revenue, 2018-2023
4.2.2 By Type – Global Biofunctional Peptide Revenue, 2024-2029
4.2.3 By Type – Global Biofunctional Peptide Revenue Market Share, 2018-2029
4.3 By Type – Global Biofunctional Peptide Sales & Forecasts
4.3.1 By Type – Global Biofunctional Peptide Sales, 2018-2023
4.3.2 By Type – Global Biofunctional Peptide Sales, 2024-2029
4.3.3 By Type – Global Biofunctional Peptide Sales Market Share, 2018-2029
4.4 By Type – Global Biofunctional Peptide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biofunctional Peptide Market Size, 2022 & 2029
5.1.2 Food and Beverages
5.1.3 Cosmetics
5.1.4 Others
5.2 By Application – Global Biofunctional Peptide Revenue & Forecasts
5.2.1 By Application – Global Biofunctional Peptide Revenue, 2018-2023
5.2.2 By Application – Global Biofunctional Peptide Revenue, 2024-2029
5.2.3 By Application – Global Biofunctional Peptide Revenue Market Share, 2018-2029
5.3 By Application – Global Biofunctional Peptide Sales & Forecasts
5.3.1 By Application – Global Biofunctional Peptide Sales, 2018-2023
5.3.2 By Application – Global Biofunctional Peptide Sales, 2024-2029
5.3.3 By Application – Global Biofunctional Peptide Sales Market Share, 2018-2029
5.4 By Application – Global Biofunctional Peptide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biofunctional Peptide Market Size, 2022 & 2029
6.2 By Region – Global Biofunctional Peptide Revenue & Forecasts
6.2.1 By Region – Global Biofunctional Peptide Revenue, 2018-2023
6.2.2 By Region – Global Biofunctional Peptide Revenue, 2024-2029
6.2.3 By Region – Global Biofunctional Peptide Revenue Market Share, 2018-2029
6.3 By Region – Global Biofunctional Peptide Sales & Forecasts
6.3.1 By Region – Global Biofunctional Peptide Sales, 2018-2023
6.3.2 By Region – Global Biofunctional Peptide Sales, 2024-2029
6.3.3 By Region – Global Biofunctional Peptide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biofunctional Peptide Revenue, 2018-2029
6.4.2 By Country – North America Biofunctional Peptide Sales, 2018-2029
6.4.3 US Biofunctional Peptide Market Size, 2018-2029
6.4.4 Canada Biofunctional Peptide Market Size, 2018-2029
6.4.5 Mexico Biofunctional Peptide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biofunctional Peptide Revenue, 2018-2029
6.5.2 By Country – Europe Biofunctional Peptide Sales, 2018-2029
6.5.3 Germany Biofunctional Peptide Market Size, 2018-2029
6.5.4 France Biofunctional Peptide Market Size, 2018-2029
6.5.5 U.K. Biofunctional Peptide Market Size, 2018-2029
6.5.6 Italy Biofunctional Peptide Market Size, 2018-2029
6.5.7 Russia Biofunctional Peptide Market Size, 2018-2029
6.5.8 Nordic Countries Biofunctional Peptide Market Size, 2018-2029
6.5.9 Benelux Biofunctional Peptide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biofunctional Peptide Revenue, 2018-2029
6.6.2 By Region – Asia Biofunctional Peptide Sales, 2018-2029
6.6.3 China Biofunctional Peptide Market Size, 2018-2029
6.6.4 Japan Biofunctional Peptide Market Size, 2018-2029
6.6.5 South Korea Biofunctional Peptide Market Size, 2018-2029
6.6.6 Southeast Asia Biofunctional Peptide Market Size, 2018-2029
6.6.7 India Biofunctional Peptide Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biofunctional Peptide Revenue, 2018-2029
6.7.2 By Country – South America Biofunctional Peptide Sales, 2018-2029
6.7.3 Brazil Biofunctional Peptide Market Size, 2018-2029
6.7.4 Argentina Biofunctional Peptide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biofunctional Peptide Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biofunctional Peptide Sales, 2018-2029
6.8.3 Turkey Biofunctional Peptide Market Size, 2018-2029
6.8.4 Israel Biofunctional Peptide Market Size, 2018-2029
6.8.5 Saudi Arabia Biofunctional Peptide Market Size, 2018-2029
6.8.6 UAE Biofunctional Peptide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 American Peptide Company Inc.
7.1.1 American Peptide Company Inc. Company Summary
7.1.2 American Peptide Company Inc. Business Overview
7.1.3 American Peptide Company Inc. Biofunctional Peptide Major Product Offerings
7.1.4 American Peptide Company Inc. Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.1.5 American Peptide Company Inc. Key News & Latest Developments
7.2 Phermpep Co. Ltd.
7.2.1 Phermpep Co. Ltd. Company Summary
7.2.2 Phermpep Co. Ltd. Business Overview
7.2.3 Phermpep Co. Ltd. Biofunctional Peptide Major Product Offerings
7.2.4 Phermpep Co. Ltd. Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.2.5 Phermpep Co. Ltd. Key News & Latest Developments
7.3 ALEXIS Corporation
7.3.1 ALEXIS Corporation Company Summary
7.3.2 ALEXIS Corporation Business Overview
7.3.3 ALEXIS Corporation Biofunctional Peptide Major Product Offerings
7.3.4 ALEXIS Corporation Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.3.5 ALEXIS Corporation Key News & Latest Developments
7.4 Ashland Inc.
7.4.1 Ashland Inc. Company Summary
7.4.2 Ashland Inc. Business Overview
7.4.3 Ashland Inc. Biofunctional Peptide Major Product Offerings
7.4.4 Ashland Inc. Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.4.5 Ashland Inc. Key News & Latest Developments
7.5 Promega Corporation
7.5.1 Promega Corporation Company Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Biofunctional Peptide Major Product Offerings
7.5.4 Promega Corporation Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.5.5 Promega Corporation Key News & Latest Developments
7.6 Advanced Bioconcept Company
7.6.1 Advanced Bioconcept Company Company Summary
7.6.2 Advanced Bioconcept Company Business Overview
7.6.3 Advanced Bioconcept Company Biofunctional Peptide Major Product Offerings
7.6.4 Advanced Bioconcept Company Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.6.5 Advanced Bioconcept Company Key News & Latest Developments
7.7 Arlak Biotech
7.7.1 Arlak Biotech Company Summary
7.7.2 Arlak Biotech Business Overview
7.7.3 Arlak Biotech Biofunctional Peptide Major Product Offerings
7.7.4 Arlak Biotech Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.7.5 Arlak Biotech Key News & Latest Developments
7.8 WN Pharmaceuticals Ltd.
7.8.1 WN Pharmaceuticals Ltd. Company Summary
7.8.2 WN Pharmaceuticals Ltd. Business Overview
7.8.3 WN Pharmaceuticals Ltd. Biofunctional Peptide Major Product Offerings
7.8.4 WN Pharmaceuticals Ltd. Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.8.5 WN Pharmaceuticals Ltd. Key News & Latest Developments
7.9 Anaspec Inc.
7.9.1 Anaspec Inc. Company Summary
7.9.2 Anaspec Inc. Business Overview
7.9.3 Anaspec Inc. Biofunctional Peptide Major Product Offerings
7.9.4 Anaspec Inc. Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.9.5 Anaspec Inc. Key News & Latest Developments
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Summary
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific Biofunctional Peptide Major Product Offerings
7.10.4 Thermo Fisher Scientific Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.10.5 Thermo Fisher Scientific Key News & Latest Developments
7.11 Seagarden AS
7.11.1 Seagarden AS Company Summary
7.11.2 Seagarden AS Biofunctional Peptide Business Overview
7.11.3 Seagarden AS Biofunctional Peptide Major Product Offerings
7.11.4 Seagarden AS Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.11.5 Seagarden AS Key News & Latest Developments
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Company Summary
7.12.2 Novo Nordisk A/S Biofunctional Peptide Business Overview
7.12.3 Novo Nordisk A/S Biofunctional Peptide Major Product Offerings
7.12.4 Novo Nordisk A/S Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.12.5 Novo Nordisk A/S Key News & Latest Developments
7.13 Merck KGaA
7.13.1 Merck KGaA Company Summary
7.13.2 Merck KGaA Biofunctional Peptide Business Overview
7.13.3 Merck KGaA Biofunctional Peptide Major Product Offerings
7.13.4 Merck KGaA Biofunctional Peptide Sales and Revenue in Global (2018-2023)
7.13.5 Merck KGaA Key News & Latest Developments
8 Global Biofunctional Peptide Production Capacity, Analysis
8.1 Global Biofunctional Peptide Production Capacity, 2018-2029
8.2 Biofunctional Peptide Production Capacity of Key Manufacturers in Global Market
8.3 Global Biofunctional Peptide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biofunctional Peptide Supply Chain Analysis
10.1 Biofunctional Peptide Industry Value Chain
10.2 Biofunctional Peptide Upstream Market
10.3 Biofunctional Peptide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biofunctional Peptide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生体機能性ペプチドの世界市場見通し2023年-2029年(Biofunctional Peptide Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

生体機能性ペプチドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp